Ascendis Pharma Begins Ordinary Share Trading on Nasdaq, Completes ADS Exchange
Ascendis Pharma commenced trading its ordinary shares on The Nasdaq Global Select Market today, replacing its American Depositary Shares. All outstanding ADSs were mandatorily exchanged at a one-to-one ratio, and the ordinary shares now trade under ticker ASND with CUSIP K08588103 and ISIN DK0060606333.
1. Listing Transition
Ascendis Pharma commenced trading its ordinary shares on The Nasdaq Global Select Market today, replacing its American Depositary Shares that previously traded under ticker ASND.
2. ADS Exchange Details
On April 8, the company mandated the exchange of all outstanding ADSs for one ordinary share each, with the last ADS trading day on April 17 and full conversion completed by April 20.
3. Trading Identifiers
The ordinary shares now trade under ticker ASND using CUSIP K08588103 and ISIN DK0060606333, aligning share structure globally and enabling direct access for investors without ADS vehicles.
4. Investor Resources
A dedicated FAQ section on the Ascendis Pharma website provides guidance on the listing change and ADS exchange process for shareholders evaluating their holdings.